Vertex Pharmaceuticals Incorporated · NASDAQ:VRTX

van Grunsven Jasper received 8,682 Vertex Pharmaceuticals Incorporated shares as an award (Form 4)

Traded Sep 8, 2026 · Filed Sep 10, 2026

On Sep 8, 2026, van Grunsven Jasper (EVP, CP and NPPO) received 8,682 Vertex Pharmaceuticals Incorporated shares as an award, leaving 8,682 shares. Filed Sep 10, 2026 (Form 4).

Awarded
8,682 shares
Holding after
8,682 shares
Trading plan
No
Role
EVP, CP and NPPO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 8, 2026Common StockAward8,6828,682Direct

Source

View original at SEC

Related